Literature DB >> 8871667

Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.

J N Flynn1, P Keating, M J Hosie, M Mackett, E B Stephens, J A Beatty, J C Neil, O Jarrett.   

Abstract

Animal models of HIV-1 have a key role to play in elucidation of the cellular mechanisms responsible for protective immunity. Vaccination of domestic cats with whole inactivated feline immunodeficiency virus (FIV) elicits virus-neutralizing Abs and virus-specific CTL in the peripheral blood and lymphoid organs and affords protection from homologous virus challenge. In the present study we confirm the induction of virus-specific CTL following immunization with whole inactivated FIV vaccine and demonstrate that cats are protected for up to 1 yr following vaccination. Long term protection in vaccinated cats correlates with both higher levels of FIV Env-specific CTL in the peripheral blood following vaccination and the presence of FIV Env-specific memory CD8+ CTL in the lymph nodes, which persist for up to 1 yr following challenge in the absence of detectable virus. The CTL responses observed in vaccinated protected cats differ qualitatively from those in FIV-infected cats. The latter cats either do not generate a memory CTL response or exhibit a Gag-specific memory CTL response. These results show that the protective immunity observed in whole inactivated virus-vaccinated cats is associated with the induction of high levels of Env-specific CTL activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871667

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted.

Authors:  D Matteucci; M Pistello; P Mazzetti; S Giannecchini; D Del Mauro; I Lonetti; L Zaccaro; C Pollera; S Specter; M Bendinelli
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of Env.

Authors:  Margaret J Hosie; Dieter Klein; James M Binley; Thomas H Dunsford; Oswald Jarrett; James C Neil; Elzbieta Knapp; Simone Giannecchini; Donatella Matteucci; Mauro Bendinelli; James A Hoxie; Brian J Willett
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection.

Authors:  J N Flynn; C A Cannon; J C Neil; O Jarrett
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood.

Authors:  J Norman Flynn; Mauro Pistello; Patrizia Isola; Lucia Zaccaro; Barbara Del Santo; Enrica Ricci; Donatella Matteucci; Mauro Bendinelli
Journal:  Clin Diagn Lab Immunol       Date:  2005-06

5.  Suppression of feline immunodeficiency virus replication in vitro by a soluble factor secreted by CD8+ T lymphocytes.

Authors:  J N Flynn; C A Cannon; D Sloan; J C Neil; O Jarrett
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

Review 6.  Overview of vaccines.

Authors:  G Ada
Journal:  Mol Biotechnol       Date:  1997-10       Impact factor: 2.695

7.  AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccine.

Authors:  P Mazzetti; S Giannecchini; D Del Mauro; D Matteucci; P Portincasa; A Merico; C Chezzi; M Bendinelli
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 8.  Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat.

Authors:  Holly M Kolenda-Roberts; Leah A Kuhnt; Ryan N Jennings; Ayalew Mergia; Nazareth Gengozian; Calvin M Johnson
Journal:  Front Biosci       Date:  2007-05-01

9.  DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies.

Authors:  M J Hosie; J N Flynn; M A Rigby; C Cannon; T Dunsford; N A Mackay; D Argyle; B J Willett; T Miyazawa; D E Onions; O Jarrett; J C Neil
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Polymorphisms and tissue expression of the feline leukocyte antigen class I loci FLAI-E, FLAI-H, and FLAI-K.

Authors:  Jennifer C Holmes; Savannah G Holmer; Peter Ross; Adam S Buntzman; Jeffrey A Frelinger; Paul R Hess
Journal:  Immunogenetics       Date:  2013-06-30       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.